Selegiline 5mg


Selegiline (Figure 1) is a selective and irreversible mono-oxidase inhibitor, type B, (MAO-B) which is mainly used for the treatment of Parkinson’s disease (PD), as well as for depression [1; 2]. Selegiline was developed in the 1960s as a psychic energiser and is registered in more than 60 countries [3]. More recently, selegiline has been investigated as a possible therapy in ending tobacco smoking [4]. In this manner, selegiline was found to inhibit [mouse] nicotine metabolism [4]. In terms of treating depression, the selegiline transdermal system (skin patch system) was approved by the FDA (2006) for treatment of major depressive disorder (MDD) [5].


Selegiline (Figure 1)

Figure 1


Selegiline, also known as (-)-deprenyl continues to be used for the clinical treatment of patients with Parkinson’s disease (PD) [6], with some antidepressant activity [Culpepper et al., 2008]. Selegiline is considered a type B MAO. Type A MAO is concentrated in the brain and intestine where primary substrates in the brain are dopamine (DA) and serotonin (5-HT) [7]. Type B MAO is focused in anatomic brain regions that are abundant in serotonergic neurons [7]. Currently, selegiline, a type B MAO, is used as an adjuvant treatment against Parkinson’s disease (PD) at a dose of 10mg/day [7]. Selegiline offers neuroprotection as evidenced by its ability to block the parkinsonism-inducing effects of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), a neurotoxin which induces abnormal behaviours similar to those observed in Parkinson’s Disease (PD) [8; 9]. To assess the degree of MAO-A and MAO-B inhibition in the body, -phenylethylamine (PEA) is measured in the urine since MAO-B catalyses the oxidation of this compound [10].

Treatment with selegiline carries out the following pharmacological effects:

  1. Increased neurotransmitter dopamine concentration in the CNS
  2. Decrease of oxidative and nutrient stress by reducing the hydrogen peroxide (H2O2) production.
  3. Long-term protective mechanism against oxidative damage [11].

Selegiline is metabolised, in the liver, into three metabolites: desmethyl-selegiline, amphetamine and methamphetamine (Figure 2) [12], with all three metabolites pharmacologically active [13]. Furthermore, selegiline is metabolised by the gastrointestinal tract, lung and liver in dogs [12]. One study assessing the metabolism of selegiline hydrochloride (HCl) – doses 10, 5, and 2.5mg – in humans found nine metabolites in excreted urine after 2 days of the ranged dose [14]. In addition, metabolites of selegiline hydrochloride comprised 44-58% of the original dose [14]. In treating depression, the selegiline transdermal system allows for delivery of selegiline into the bloodstream where it selectively inhibits MAO-A and MAO-B in the brain; this is achieved without inhibiting MAO-A activity in the gastrointestinal tract, which could otherwise lead to hypertension and possible stroke [15; 16].

Selegiline (Figure 2)

Figure 2



Oral selegiline dosages of 0.5mg/kg and 5mg/kg in rat studies have shown a varying effect on different organs, and selegiline’s MAO inhibition [11]. When comparing MAO-A and MOA-B, selegiline, in the rat brain, liver and bowel seemed to inhabit MAO-B in higher concentrations than MAO-A [11]. A 5mg/kg dose exhibited greater MAO-B inhibition than 0.5mg/kg dose [11]. An oral dose of 10mg selegiline is rapidly absorbed and metabolised to all three metabolites (Figure 2), with an elimination half-life of ~1.5 hours [12].

Selegiline and depression

For treating depressive symptoms, the Selegiline transdermal system – EMSAM patch – has been established as a generally well tolerated system at a dose of 6mg per 24 hours, and has shown safety without tyramine dietary restrictions are not required [5; 15]. For higher doses – 9mg and 12mg – the FDA does require that a tyramine-free diet be followed [16]. Tyramine is found in many foods (70) and beverages and is normally metabolised in the gut by MAO-A [16]. At higher doses selegiline loses its selectivity to the monoamine oxidase B inhibitor (MAO-A) and has the potential to interact with tyramine [15]. In studying the efficacy and safety of transdermal selegiline in adults with major depression, and with a tyramine-restricted diet in place (up to 2-weeks post selegiline administration), a 20mg dose given for 6 weeks was found to be superior to placebo [17].

Selegiline use for treating Canine cognitive dysfunction (CDS)

Selegiline hydrochloride (HCl) at doses of 0.5 – 1.0mg/kg has been shown to be an effective treatment in canine cognitive dysfunction (CDS) [18]. 641 dogs were administered selegiline – 0.5-1mg/kg – orally, once daily for 60 days. Dog owners were asked to rate the improvement in clinical signs and after 30 days selegiline treatment 80% of dogs had improvement in clinical CDS symptoms [18].


Overall, selegiline has been generally accepted as a safe drug since its comparative effects – fatigue, vertigo, constipation, insomnia, nausea, sweating, anxiety and involuntary movements – are identical to those observed, and caused, in placebo [9]. However, selegiline has been reported to cause insomnia in a greater proportion of patients – when treating Parkinson’s disease (PD) – when compared to placebo [19]. In addition, selegiline interacts with few other drugs such as pethidine and fluoxetine [19].

Side effects

Adverse Effects and events associated with selegiline, in conjunction with fluoxetine, include, agitation, hypertension, mania, sweating, shivers and tachycardia [19]. In addition, it has previously been advised to avoid combination of selegiline with pethidine [19]. Selegiline is usually well tolerated when administered alone; however, frequent adverse events include insomnia, nausea, headaches and dizziness [19]. Selegiline patches (EMSAM) has very little side effects, compared to other antidepressant drugs [16]. Skin irritations have been noted with EMSAM use, as the system is a transdermal application [16].

Quantity of Tablets

30 Tablets, 60 Tablets, 90 Tablets, 120 Tablets, 180 Tablets, 300 Tablets


There are no reviews yet.

Be the first to review “Selegiline 5mg”

Your email address will not be published. Required fields are marked *

Shopping Cart